Abeona Therapeutics faces a pivotal FDA decision after a CRL-led crash and partial rebound in pz-cel’s valuation. Check out ...

Mesoblast Limited’s MESO share price has surged by 5.14%, which has investors questioning if this is right time to sell.

Avicanna reported annual revenue of CA$25.5 million ($18.38 million) for the year ended December 31, 2024, up 52% compared to ...

LEO Pharma and the Parker Institute at Copenhagen University Hospital have entered into a three-year academic partnership aimed at advancing dermatology research. The alliance will focus on enhancing ...

which is developing the first and only protein replacement therapy currently being investigated for the treatment of dystrophic epidermolysis bullosa (DEB). The second, was Premacure AB ...

Ligand Pharmaceuticals offers biotech exposure with reduced risk through its royalty platform. Discover why its valuation now ...

DEB is one of the more severe forms of the epidermolysis bullosa (EB) group – sometimes ... Before now, the only treatment was palliative care. Vyjuvek – which has been approved for both ...

Hannah Campbell announced the tragic news of her infant's death on April 8 with a TikTok post shared to over 769,000 ...

Trailer: Pearl Jam frontman Eddie Vedder's new documentary, 'Matter of Time, ' raises awareness and funds for epidermolysis ...

Pearl Jam frontman Eddie Vedder is releasing a new documentary, “Matter of Time,” this summer on a project he and his wife Jill have been working on to find a cure for epidermolysis bullosa ...

Matter of Time,” a documentary featuring Pearl Jam frontman Eddie Vedder that is set to debut this summer at the Tribeca Film ...